Авторы – члены международной комиссии

Michael Reid, University of California San Francisco, San Francisco, CA, USA

Nimalan Arinaminpathy, Imperial College London, London, UK

Amy Bloom, United States Agency for International Development, Washington, DC

Barry Bloom, Harvard University, Cambridge, MA, USA

Catharina Boehme, Foundation for Innovative New Diagnostics, Geneva, Switzerland

Richard Chaisson, Johns Hopkins School of Medicine, Baltimore, MA, USA

Daniel Chin, Bill & Melinda Gates Foundation, Seattle, WA, USA

Gavin Churchyard, The Aurum Institute, Johannesburg, South Africa

Helen Cox, University of Cape Town, Cape Town, South Africa

Lucica Ditiu, Stop TB Partnership, WHO, Geneva, Switzerland

Mark Dybul, Georgetown University, Washington, DC, USA

Jeremy Farrar, The Wellcome Trust, London, UK

Anthony Fauci, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA

Endalkachew Fekadu, Volunteer Health Services, Addis Ababa, Ethiopia

Paula L Fujiwara, The International Union Against Tuberculosis and Lung Disease, Paris, France

Tim Hallett, Imperial College London, London, UK

Christy Hanson, Bill & Melinda Gates Foundation, Seattle, WA, USA

Mark Harrington, Treatment Action Group, New York, NY, USA

Nick Herbert, Global TB Caucus, Houses of Parliament, London, UK

Philip Hopewell, University of California San Francisco, San Francisco, CA, USA

Chieko Ikeda, Ministry of Heath, Labor and Welfare, Tokyo, Japan

Dean Jamison, University of California San Francisco, San Francisco, CA, USA

Aamir Khan, Interactive Research & Development, Karachi, Pakistan

Irene Koek, United States Agency for International Development, Washington, DC

Nalini Krishnan, Resource Group for Education and Advocacy for Community Health, India

Aaron Motsoaledi, South African National Department of Health, Pretoria, South Africa

Madhukar Pai, Department of Epidemiology, Biostatistics and Occupational Health

Mario Raviglione, University of Milan, Milan, Italy, Global Studies Institute, University of Geneva, Geneva, Switzerland

Almaz Sharman, Academy of Preventive Medicine, Almaty, Kazakhstan

Peter Small, Stony Brook University, Stony Brook, NY, USA

Soumya Swaminathan, WHO, Geneva, Switzerland

Zelalem Temesgen, Mayo Clinic, Rochester, MI, USA

Anna Vassall, London School of Hygiene and Tropical Medicine, London, UK, University of Amsterdam, Amsterdam, Netherlands

Nandita Venkatesan, The Economic Times, Mumbai, India

Kitty van Weezenbeek, KNCV Tuberculosis Foundation, The Haag, Netherlands

Gavin Yamey, Duke University, Durham, NC, USA

Eric Goosby, University of California San Francisco, San Francisco, CA, USA

На русский язык материал переведен доктором медицинских наук Аккумис Салхановой

Алмаз Шарман, Президент Академии профилактической медицины
Казахстан, 050008, г. Алматы, ул. Клочкова 66, офис 601
+7 (727) 317-8855
academypm@outlook.com